Evidence map›Paper›PMID 28498833›Full record

ArticlePloS one2017

Assessment of the quality of DNA from various formalin-fixed paraffin-embedded (FFPE) tissues and the use of this DNA for next-generation sequencing (NGS) with no artifactual mutation.

Naoki Einaga, Akio Yoshida, Hiroko Noda, Masaaki Suemitsu, Yuki Nakayama, Akihisa Sakurada, Yoshiko Kawaji, Hiromi Yamaguchi, Yasushi Sasaki, Takashi Tokino and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 113 citations in OpenAlex.

  1. Assessing the Effects of a 3-Dimensional (3D) Pathology Tissue-Processing Workflow on Downstream Molecular Analyses.Laboratory investigation; a journal of technical methods and pathology · 2026
    Article
  2. Cell-Free DNA-Based Theranostics for Inflammatory Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Multi-Gene Next-Generation Sequencing Panel for Analysis ofInternational journal of molecular sciences · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Effect of Antigen Retrieval on Genomic DNA From Immunodissected Samples.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Article
  17. Review
  18. Validation of AmpliSeq NGS Panel forLife (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Case report:Frontiers in oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Naoki EinagaDepartment of Pathology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Akio YoshidaDepartment of Pathology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Hiroko NodaDepartment of Pathology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Masaaki SuemitsuDepartment of Pathology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Yuki NakayamaDepartment of Pathology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Akihisa SakuradaDepartment of Pathology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Yoshiko KawajiDepartment of Pathology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Hiromi YamaguchiDepartment of Pathology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Yasushi SasakiDepartment of Medical Genome Sciences, Sapporo Medical University, Sapporo, Hokkaido, Japan.
Takashi TokinoDepartment of Medical Genome Sciences, Sapporo Medical University, Sapporo, Hokkaido, Japan.
Mariko EsumiDepartment of Pathology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Nihon University · JPSapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Formalin-fixed, paraffin-embedded (FFPE) tissues used for pathological diagnosis are valuable for studying cancer genomics. In particular, laser-capture microdissection of target cells determined by histopathology combined with FFPE tissue section immunohistochemistry (IHC) enables precise analysis by next-generation sequencing (NGS) of the genetic events occurring in cancer. The result is a new strategy for a pathological tool for cancer diagnosis: 'microgenomics'. To more conveniently and precisely perform microgenomics, we revealed by systematic analysis the following three details regarding FFPE DNA compared with paired frozen tissue DNA. 1) The best quality of FFPE DNA is obtained by tissue fixation with 10% neutral buffered formalin for 1 day and heat treatment of tissue lysates at 95°C for 30 minutes. 2) IHC staining of FFPE tissues decreases the quantity and quality of FFPE DNA to one-fourth, and antigen retrieval (at 120°C for 15 minutes, pH 6.0) is the major reason for this decrease. 3) FFPE DNA prepared as described herein is sufficient for NGS. For non-mutated tissue specimens, no artifactual mutation occurs during FFPE preparation, as shown by precise comparison of NGS of FFPE DNA and paired frozen tissue DNA followed by validation. These results demonstrate that even FFPE tissues used for routine clinical diagnosis can be utilized to obtain reliable NGS data if appropriate conditions of fixation and validation are applied.

Indexed as

High-Throughput Nucleotide SequencingParaffin EmbeddingAdaptor Proteins, Signal TransducingAnimalsCell Adhesion MoleculesCell Adhesion Molecules, NeuronalCheckpoint Kinase 2DNAFormaldehydeGuanylate KinasesImmunohistochemistryLiverMaleMutationPolymerase Chain ReactionRatsAdaptor Proteins, Signal TransducingCell Adhesion MoleculesCell Adhesion Molecules, NeuronalCheckpoint Kinase 2CHEK2 protein, humanDNAFGFR3 protein, humanFormaldehydeGuanylate KinasesMAGI1 protein, humanReceptor, Fibroblast Growth Factor, Type 3

Identifiers

PMID28498833
PMCPMC5428915
OpenAlexW2613808212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.